Drug profile · INN
garenoxacin mesilate hydrate
GENINAX
garenoxacin mesilate hydrate (GENINAX) is a bacterial dna gyrase inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — garenoxacin mesilate hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
garenoxacin mesilate hydrate (GENINAX) is a bacterial dna gyrase inhibitor.
Key facts
INN garenoxacin mesilate hydrate
Brand GENINAX
Mechanism Bacterial DNA gyrase inhibitor
Target Bacterial DNA gyrase
Mechanism of action
Bacterial DNA gyrase inhibitor
Primary target: Bacterial DNA gyrase
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is garenoxacin mesilate hydrate?
garenoxacin mesilate hydrate (GENINAX) is a bacterial dna gyrase inhibitor.
What is the brand name for garenoxacin mesilate hydrate?
GENINAX is a marketed brand name for garenoxacin mesilate hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.